{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T15:05:36Z","timestamp":1779894336531,"version":"3.53.1"},"reference-count":50,"publisher":"BMJ","issue":"5","license":[{"start":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T00:00:00Z","timestamp":1779840000000},"content-version":"unspecified","delay-in-days":26,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81902857"],"award-info":[{"award-number":["81902857"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["J Immunother Cancer"],"accepted":{"date-parts":[[2026,3,30]]},"published-print":{"date-parts":[[2026,5]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The N-terminal domain of gasdermin D (GSDMD) is a known suppressor of prostate cancer (PCa), primarily recognized for its tumoricidal pyroptotic function. However, research on the full-length GSDMD protein and its relationship with PCa remains unexplored. Therefore, the aim of this study was to investigate the potential non-pyroptotic mechanism of action of GSDMD in preventing PCa immune evasion.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The study used GSDMD deletion models to assess its impact on tumor progression and immune cell profiles. Molecular techniques, including protein interaction analysis, were employed to identify the binding partner of GSDMD and the subsequent signaling pathways. Correlative analysis was performed between GSDMD expression and immune markers in human PCa samples.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      GSDMD deletion increased tumor progression and reduced survival, cytotoxic T lymphocyte (CTL) activation\/infiltration and tumor cell susceptibility to T-cell death, promoting an immunosuppressive tumor microenvironment (TME). GSDMD-bound laminin subunit gamma-2 (LAMC2), thus inducing its ubiquitin-mediated degradation. Consequently, GSDMD deficiency stabilized LAMC2, driving M2 macrophage polarization and CXC motif chemokine ligand 5 (CXCL5) secretion. CXCL5 interacted with CXCR2 to activate the AKT\/NF-\u03baB axis, increasing vascular endothelial growth factor (VEGF)\/vascular endothelial growth factor receptor 2 (VEGFR2) and suppressing CTL activity. GSDMD expression in human PCa positively correlated with CD8\n                      <jats:sup>+<\/jats:sup>\n                      T-cell infiltration and negatively with M2-phenotype tumor-associated macrophages.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study reveals a novel non-pyroptotic pathway through which GSDMD inhibits PCa immune evasion by targeting LAMC2 for degradation, thereby preventing the establishment of an immunosuppressive TME. The findings suggest that activating GSDMD represents a promising therapeutic strategy to reprogram the TME from immunosuppressive (\u201ccold\u201d) to immunoreactive (\u201chot\u201d), potentially enhancing the efficacy of immunotherapy in advanced PCa.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/jitc-2025-014533","type":"journal-article","created":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T14:35:10Z","timestamp":1779892510000},"page":"e014533","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Gasdermin D antagonizes immunosuppression in prostate cancer by inducing LAMC2 degradation to block M2 macrophage polarization"],"prefix":"10.1136","volume":"14","author":[{"given":"Qindan","family":"Du","sequence":"first","affiliation":[{"name":"Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Han","sequence":"additional","affiliation":[{"name":"Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yumeng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[{"name":"Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ao","family":"Sun","sequence":"additional","affiliation":[{"name":"Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Wang","sequence":"additional","affiliation":[{"name":"Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongquan","family":"Chen","sequence":"additional","affiliation":[{"name":"Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, China"},{"name":"Public Health Research Center and Department of Public Health and Preventive Medicine, Jiangnan University, Wuxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1803-5255","authenticated-orcid":false,"given":"Xiaoying","family":"Wang","sequence":"additional","affiliation":[{"name":"Wuxi School of Medicine, Jiangnan University, Wuxi, Jiangsu, China"},{"name":"Public Health Research Center and Department of Public Health and Preventive Medicine, Jiangnan University, Wuxi, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,5,27]]},"reference":[{"key":"2026052707350848000_14.5.e014533.1","doi-asserted-by":"crossref","unstructured":"He YD , Xu WD , Xiao YT , et al . Targeting signaling pathways in prostate cancer: mechanisms and clinical trials. Sig Transduct Target Ther 2022;7. doi:10.1038\/s41392-022-01042-7","DOI":"10.1038\/s41392-022-01042-7"},{"key":"2026052707350848000_14.5.e014533.2","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/s43587-025-00892-4","article-title":"Author Correction: Single-cell and spatial RNA sequencing identify divergent microenvironments and progression signatures in early- versus late-onset prostate cancer","volume":"5","author":"Cheng","year":"2025","journal-title":"Nat Aging"},{"key":"2026052707350848000_14.5.e014533.3","doi-asserted-by":"crossref","unstructured":"Hawley JE , Obradovic AZ , Dallos MC , et al . Anti-PD-1 immunotherapy with androgen deprivation therapy induces robust immune infiltration in metastatic castration-sensitive prostate cancer. Cancer Cell 2023;41.","DOI":"10.1016\/j.ccell.2023.10.006"},{"key":"2026052707350848000_14.5.e014533.4","doi-asserted-by":"publisher","DOI":"10.1038\/s41556-020-00613-6"},{"key":"2026052707350848000_14.5.e014533.5","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2019.12.011"},{"key":"2026052707350848000_14.5.e014533.6","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2016.69.1584"},{"key":"2026052707350848000_14.5.e014533.7","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.eururo.2025.02.001","article-title":"T-cell Engagers in Prostate Cancer","volume":"87","author":"Hage Chehade","year":"2025","journal-title":"Eur Urol"},{"key":"2026052707350848000_14.5.e014533.8","doi-asserted-by":"crossref","DOI":"10.1126\/science.abp8964","article-title":"The extracellular matrix and the immune system: A mutually dependent relationship","volume":"379","author":"Sutherland","year":"2023","journal-title":"Science"},{"key":"2026052707350848000_14.5.e014533.9","doi-asserted-by":"crossref","unstructured":"Hu Q , Zhu YF , Mei J , et al . Extracellular matrix dynamics in tumor immunoregulation: from tumor microenvironment to immunotherapy. J Hematol Oncol 2025;18. doi:10.1186\/s13045-025-01717-y","DOI":"10.1186\/s13045-025-01717-y"},{"key":"2026052707350848000_14.5.e014533.10","doi-asserted-by":"crossref","unstructured":"Chen M , Zhao S , Xie X , et al . Role of Tunneling Nanotubes in Arachidonic Acid Transfer and Macrophage Function Reprogramming in Intrahepatic Cholangiocarcinoma. Adv Sci (Weinh) 2025;12. doi:10.1002\/advs.202500148","DOI":"10.1002\/advs.202500148"},{"key":"2026052707350848000_14.5.e014533.11","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-04999-8","article-title":"Monoacylglycerol lipase regulates cannabinoid receptor 2-dependent macrophage activation and cancer progression","volume":"9","author":"Xiang","year":"2018","journal-title":"Nat Commun"},{"key":"2026052707350848000_14.5.e014533.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2021.03.045"},{"key":"2026052707350848000_14.5.e014533.13","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2022-329147"},{"key":"2026052707350848000_14.5.e014533.14","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004400","article-title":"PD-L1 blockade restores CAR T cell activity through IFN-\u03b3-regulation of CD163+ M2 macrophages","volume":"10","author":"Yamaguchi","year":"2022","journal-title":"J Immunother Cancer"},{"key":"2026052707350848000_14.5.e014533.15","doi-asserted-by":"crossref","DOI":"10.1038\/s41698-024-00522-z","article-title":"Targeting M2-like tumor-associated macrophages is a potential therapeutic approach to overcome antitumor drug resistance","volume":"8","author":"Wang","year":"2024","journal-title":"NPJ Precis Oncol"},{"key":"2026052707350848000_14.5.e014533.16","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2022-004763","article-title":"Targeting of GSDMD sensitizes HCC to anti-PD-1 by activating cGAS pathway and downregulating PD-L1 expression","volume":"10","author":"Lv","year":"2022","journal-title":"J Immunother Cancer"},{"key":"2026052707350848000_14.5.e014533.17","doi-asserted-by":"crossref","unstructured":"Ning H , Huang S , Lei Y , et al . Enhancer decommissioning by MLL4 ablation elicits dsRNA-interferon signaling and GSDMD-mediated pyroptosis to potentiate anti-tumor immunity. Nat Commun 2022;13. doi:10.1038\/s41467-022-34253-1","DOI":"10.1038\/s41467-022-34253-1"},{"key":"2026052707350848000_14.5.e014533.18","doi-asserted-by":"crossref","unstructured":"Gao K , Xi W , Ni J , et al . Genetically modified extracellular vesicles loaded with activated gasdermin D potentially inhibit prostate-specific membrane antigen-positive prostate carcinoma growth and enhance immunotherapy. Biomaterials 2025;315. doi:10.1016\/j.biomaterials.2024.122894","DOI":"10.1016\/j.biomaterials.2024.122894"},{"key":"2026052707350848000_14.5.e014533.19","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2024.08.007"},{"key":"2026052707350848000_14.5.e014533.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.devcel.2022.09.013"},{"key":"2026052707350848000_14.5.e014533.21","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1161\/ATVBAHA.123.320612","article-title":"Macrophage-Derived GSDMD Plays an Essential Role in Atherosclerosis and Cross Talk Between Macrophages via the Mitochondria-STING-IRF3\/NF-\u03baB Axis","volume":"44","author":"Fan","year":"2024","journal-title":"ATVB"},{"key":"2026052707350848000_14.5.e014533.22","doi-asserted-by":"crossref","first-page":"167","DOI":"10.4049\/jimmunol.210.Supp.167.01","article-title":"Biphasic JNK signaling reveals distinct MAP3K complexes licensing inflammasome formation and pyroptosis","volume":"210","author":"Bradfield","year":"2023","journal-title":"J Immunol"},{"key":"2026052707350848000_14.5.e014533.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2023.122123"},{"key":"2026052707350848000_14.5.e014533.24","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aat2738","article-title":"Chemical disruption of the pyroptotic pore-forming protein gasdermin D inhibits inflammatory cell death and sepsis","volume":"3","author":"Rathkey","year":"2018","journal-title":"Sci Immunol"},{"key":"2026052707350848000_14.5.e014533.25","doi-asserted-by":"publisher","DOI":"10.1038\/s41590-020-0669-6"},{"key":"2026052707350848000_14.5.e014533.26","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1038\/s41586-023-06415-8","article-title":"De novo design of protein structure and function with RFdiffusion","volume":"620","author":"Watson","year":"2023","journal-title":"Nature New Biol"},{"key":"2026052707350848000_14.5.e014533.27","doi-asserted-by":"crossref","first-page":"142667","DOI":"10.1016\/j.ijbiomac.2025.142667","article-title":"Designed peptide binders and nanobodies as PROTAC starting points for targeted degradation of PCNA and BCL6","volume":"308","author":"Zhao","year":"2025","journal-title":"Int J Biol Macromol"},{"key":"2026052707350848000_14.5.e014533.28","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.21037\/atm-21-4507","article-title":"LAMC2 promotes the proliferation of cancer cells and induce infiltration of macrophages in non-small cell lung cancer","volume":"9","author":"Liu","year":"2021","journal-title":"Ann Transl Med"},{"key":"2026052707350848000_14.5.e014533.29","doi-asserted-by":"crossref","unstructured":"Nguyen NM , Pulkkinen L , Schlueter JA , et al . Lung development in laminin \u03b32 deficiency: abnormal tracheal hemidesmosomes with normal branching morphogenesis and epithelial differentiation. Respir Res 2006;7. doi:10.1186\/1465-9921-7-28","DOI":"10.1186\/1465-9921-7-28"},{"key":"2026052707350848000_14.5.e014533.30","doi-asserted-by":"crossref","first-page":"217595","DOI":"10.1016\/j.canlet.2025.217595","article-title":"A single-cell map of patients with non-small cell lung cancer harboring rare-driver mutations after anti-PD-1 treatment","volume":"616","author":"Fu","year":"2025","journal-title":"Cancer Lett"},{"key":"2026052707350848000_14.5.e014533.31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jtho.2024.09.1235","article-title":"EP.12E.04 Understanding the Dynamics of TKI Induced Changes in the Tumor Immune Microenvironment for Improved Therapeutic Effect","volume":"19","author":"Lu","year":"2024","journal-title":"J Thorac Oncol"},{"key":"2026052707350848000_14.5.e014533.32","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1200385"},{"key":"2026052707350848000_14.5.e014533.33","doi-asserted-by":"crossref","unstructured":"Liu Y , Mei J , Gonzales LW , et al . IL-17a and tnf-\u00b1 exert synergistic effects on expression of cxcl5 by alveolar type ii cells in vivo and in vitro. Am J Resp Crit Care 2010;181. doi:10.1164\/ajrccm-conference.2010.181.1_MeetingAbstracts.A6787","DOI":"10.1164\/ajrccm-conference.2010.181.1_MeetingAbstracts.A6787"},{"key":"2026052707350848000_14.5.e014533.34","doi-asserted-by":"crossref","unstructured":"Zhang L , Lin Y , Hu L , et al . Transient intracellular expression of PD-L1 and VEGFR2 bispecific nanobody in cancer cells inspires long-term T cell activation and infiltration to combat tumor and inhibit cancer metastasis. Mol Cancer 2025;24. doi:10.1186\/s12943-025-02253-6","DOI":"10.1186\/s12943-025-02253-6"},{"key":"2026052707350848000_14.5.e014533.35","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2002-12-3738"},{"key":"2026052707350848000_14.5.e014533.36","doi-asserted-by":"crossref","unstructured":"Tada Y , Togashi Y , Kotani D , et al . Targeting VEGFR2 with Ramucirumab strongly impacts effector\/ activated regulatory T cells and CD8 T cells in the tumor microenvironment. J Immunother Cancer 2018.","DOI":"10.1186\/s40425-018-0403-1"},{"key":"2026052707350848000_14.5.e014533.37","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-15-1605"},{"key":"2026052707350848000_14.5.e014533.38","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2014.998519","article-title":"Characterization of myeloid leukocytes and soluble mediators in pancreatic cancer: importance of myeloid-derived suppressor cells","volume":"4","author":"Karakhanova","year":"2015","journal-title":"Oncoimmunology"},{"key":"2026052707350848000_14.5.e014533.39","doi-asserted-by":"publisher","DOI":"10.1158\/2159-8290.CD-15-0224"},{"key":"2026052707350848000_14.5.e014533.40","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-13-2534"},{"key":"2026052707350848000_14.5.e014533.41","doi-asserted-by":"crossref","unstructured":"Wang M , Han Y , Yao X , et al . Hyperexpression of tumor necrosis factor receptor 2 inhibits differentiation of myeloid\u2010derived suppressor cells by instigating apolarity during ageing. MedComm 2024;5. doi:10.1002\/mco2.605","DOI":"10.1002\/mco2.605"},{"key":"2026052707350848000_14.5.e014533.42","doi-asserted-by":"publisher","DOI":"10.1136\/gutjnl-2022-329349"},{"key":"2026052707350848000_14.5.e014533.43","doi-asserted-by":"publisher","DOI":"10.1038\/nri3175"},{"key":"2026052707350848000_14.5.e014533.44","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/nature21676","article-title":"Effective combinatorial immunotherapy for castration-resistant prostate cancer","volume":"543","author":"Lu","year":"2017","journal-title":"Nature New Biol"},{"key":"2026052707350848000_14.5.e014533.45","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccell.2023.02.016"},{"key":"2026052707350848000_14.5.e014533.46","doi-asserted-by":"crossref","unstructured":"Xin Z , Lin M , Hao Z , et al . The immune landscape of human thymic epithelial tumors. Nat Commun 2022;13. doi:10.1038\/s41467-022-33170-7","DOI":"10.1038\/s41467-022-33170-7"},{"key":"2026052707350848000_14.5.e014533.47","doi-asserted-by":"publisher","DOI":"10.1002\/gene.10036"},{"key":"2026052707350848000_14.5.e014533.48","doi-asserted-by":"crossref","first-page":"137414","DOI":"10.1016\/j.ijbiomac.2024.137414","article-title":"Fatty acid dehydratase HACD3 poses protein kinase activity and promotes the malignant progression of colorectal cancer","volume":"283","author":"Wang","year":"2024","journal-title":"Int J Biol Macromol"},{"key":"2026052707350848000_14.5.e014533.49","doi-asserted-by":"publisher","DOI":"10.1038\/S41596-020-0312-X"},{"key":"2026052707350848000_14.5.e014533.50","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-024-07487-w"}],"container-title":["Journal for ImmunoTherapy of Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/jitc-2025-014533","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T14:35:16Z","timestamp":1779892516000},"score":1,"resource":{"primary":{"URL":"https:\/\/jitc.bmj.com\/lookup\/doi\/10.1136\/jitc-2025-014533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":50,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2026,5,27]]},"published-print":{"date-parts":[[2026,5]]}},"alternative-id":["10.1136\/jitc-2025-014533"],"URL":"https:\/\/doi.org\/10.1136\/jitc-2025-014533","relation":{},"ISSN":["2051-1426"],"issn-type":[{"value":"2051-1426","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5]]}}}